Freenome
Outpacing cancer starts with early detection
South San Francisco, United States · Founded 2014 · $554.0M raised
- Headquarters
- South San Francisco, California
- Employees
- 501–1000
- Founded
- 2014
- Business Model
- B2B
- Website
- freenome.com
- Total Funding
- $554.0M
- Last Round
- $254.0M Series EFeb 2024
- Rounds
- 2
About
Freenome is a high-growth biotech company developing next-generation blood tests to detect cancer in its earliest, most treatable stages. Founded in 2014 and headquartered in Brisbane, California, Freenome uses a multiomics platform that analyzes genomic, epigenomic, and proteomic biomarkers—including tumor-derived cell-free DNA—combined with machine learning to produce actionable cancer screening results from a standard blood draw. The company's lead program targets colorectal cancer (PREEMPT CRC Study) with additional programs in lung and other cancers. In 2025, Freenome entered an exclusive license agreement with Exact Sciences for its colorectal cancer blood test and announced a $330M SPAC merger to go public.
Summary
Freenome is an Artificial Intelligence company based in South San Francisco, United States, founded in 2014. It has raised $554.0M in total across 2 rounds, most recently a $254.0M Series E round in Feb 2024. Investors include Roche, Perceptive Advisors and Bain Capital Life Sciences.
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Feb 2024
Sign up to see all 2 rounds
Series D through Series E — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/freenome"><img src="https://indexed.vc/api/badge/company/freenome" alt="Freenome on Indexed.vc" width="260" height="76" /></a>